@FiercePharma: The common cry from Big Pharma this quarter: Europe's dreadful. And Parallel trade makes it worse--Reuters. More | Follow @FiercePharma
> A group of doctors and public health leaders petitioned the FDA for tighter restrictions on powerful painkillers. Report
> Novartis has restarted production of Excedrin, aiming to satisfy migraine sufferers' cries for a product that's been missing from store shelves since a recall 6 months ago. Report
> India's Lupin says it's hoping to enter the market for certain inhaled asthma drugs, with its key target a knockoff version of GlaxoSmithKline's blockbuster Advair. Report
> Sanofi's Genzyme unit was ordered to pay $50 million to settle a patent dispute with the small biotech company Shelbyzyme. Report
> Johnson & Johnson's Janssen unit launched a mobile app designed to help patients stick to their drug regimens, part of pharma's ongoing struggle to boost compliance. Report
> Drug distributor AmerisourceBergen ($ABC) posted street-beating profits despite a downward tick in sales. Report
@FierceMedDev: Hill-Rom has snatched up Aspen Surgical Products for $400 million. Release | Follow @FierceMedDev
@MarkHFierce: The fight goes on. Advamed, via Abiomed's Michael Minogue, are pushing Congress to repeal the 2.3% device tax. More | Follow @MarkHFierce
@DamianFierce: Boston Scientific posted a $3.4B second-quarter loss, citing sluggish markets abroad. News | Follow @DamianFierce
> Covidien tops expectations on strong device sales. Article
> Bard's sales rise slightly, nicked by foreign exchange rates. Report
> Device giant Terumo seeks merger with Olympus. More
Biotech News
@FierceBiotech: GE, iBio unite on plant-based production of vaccines and biologics. Item | Follow @FierceBiotech
@JohnCFierce: EIU on Astra: "So far the departure of boss David Brennan in June seems to have made little difference to the gloom surrounding the company." | Follow @JohnCFierce
@RyanMFierce: Science journos spend lots of time translating jargon into simple terms. Nature argues against some of this practice. Article | Follow @RyanMFierce
> As sales slide AstraZeneca stays fixed on rapid-fire deal strategy. Story
> Analysts bet on likely approval, pact for Amarin blockbuster AMR101. Report
> Hyperion takes standard biotech haircut on $50M IPO. News
Pharma Manufacturing News
> FDA ravages Sanofi vaccine sterility process in warning letter. Article
> Sun Pharma standardizing manufacturing globally. Story
> California county orders drugmakers to pay for drug disposal. News
> FDA to Congress: Agency can't dodge plant problems to avoid shortages. More
Vaccines News
> FDA wags finger at Sanofi for no-nos at vaccine plants. News
> GE, iBio unite on plant-based production of vaccines and biologics. Item
> Sanofi vaccine combats most viral causes of dengue. Story
> Researchers hope to turn white blood cells into a vaccine. More
> Medicago completes rapid-fire flu vaccine production. Article
> Vaxil BioTherapeutics debuts on Tel Aviv Stock Exchange. Item
And Finally... A Merck ($MRK) cancer drug exposed hidden HIV deposits in a new study, hinting at a possible cure for the disease. Report